FDA Brief

Warning letters Biologics

FDA warning letter to

Row1 Inc. dba Regenative Labs

Issued Jun 21, 2023Posted Jul 11, 2023Division of Biological Products Operations I

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps). We haven't summarized this letter yet. Read it on fda.gov.